Phaseline

Targets › CPS1

CPS1 (Carbamoyl-phosphate synthase [ammonia], mitochondrial): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Metabolic and endocrine; next expected readout Sep 2028.

Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. (UniProt, P31327)

Open in Phaseline: the race on CPS1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Rebecca Ahrens-NicklasLNP.UCD.ABE
adenine base editor (ABE) delivered by lipid nanoparticle (LNP) for urea cycle disorder ge
CPS1, OTC, ASS1, ASL, ARG1Phase 1Urea Cycle DisordersSep 2028

Conditions

Urea Cycle Disorders (1)

Modalities

protein or peptide (1)

Companies

Rebecca Ahrens-Nicklas (1)

Related targets

OTC (1) ASS1 (1) ASL (1) ARG1 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.